NCT00393146View on ClinicalTrials.gov

A Study To Investigate The Effect Of 28 Days Of Dosing With GW856553 On Patients With Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

GW856553

Study drug

Trial Locations (15)

11172

GSK Investigational Site, Bucharest

15006

GSK Investigational Site, A Coruña

15706

GSK Investigational Site, Santiago de Compostela

20983

GSK Investigational Site, Bucharest

28007

GSK Investigational Site, Madrid

28034

GSK Investigational Site, Madrid

28035

GSK Investigational Site, Madrid

28046

GSK Investigational Site, Madrid

109240

GSK Investigational Site, Moscow

115093

GSK Investigational Site, Moscow

115522

GSK Investigational Site, Moscow

119049

GSK Investigational Site, Moscow

150003

GSK Investigational Site, Yaroslavl

196247

GSK Investigational Site, Saint Pertersburg

630117

GSK Investigational Site, Moscow

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY